The quantifying relationship between the remission duration and the cardiovascular and kidney outcomes in the patients with primary nephrotic syndrome-Reference-Cited by-同舟云学术

The quantifying relationship between the remission duration and the cardiovascular and kidney outcomes in the patients with primary nephrotic syndrome

Published:2022-11-12 Issue:1 Volume:44 Page:1925-1933
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Lai Xuan¹²,Cui Zhao¹,Zhang Hua³,Zhang Yi-miao¹,Wang Fang¹,Wang Xin¹,Meng Li-qiang¹,Cheng Xu-yang¹,Liu Gang¹,Zhao Ming-hui¹⁴

Affiliation:

1. Renal Division, Peking University First Hospital; Institute of Nephrology, Peking University; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China

2. Geriatrics Department, Peking University Third Hospital, Beijing, China

3. Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China

4. Peking-Tsinghua Center for Life Sciences, Beijing, China

Funder

Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2022.2143377

Reference23 articles.

1. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

2. Nephrotic syndrome in adults

3. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The analysis of low-dose glucocorticoid maintenance therapy in patients with primary nephrotic syndrome suffering from COVID-19;Frontiers in Molecular Biosciences;2024-01-11